WOBURN, Mass., Sept. 25, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), a Company developing new technologies to create step-change improvements in crop yield that enhance global food security, announced today that Dr. Oliver Peoples, Ph.D., President and Chief Executive Officer of Yield10, will be presenting at the Ladenburg Thalmann 2018 Healthcare Conference on Tuesday October 2, 2018 at 3:30 pm ET. The conference will be held at the Sofitel Hotel in New York City.
Management will also be meeting with members of the investment community during one-on-one meetings.
Event: Ladenburg Thalmann 2018 Healthcare Conference
Date:Tuesday, October 2, 2018
Time: 3:30 pm (ET)
Location:Sofitel Hotel, Track 6 - Madeleine
A live audio webcast and copy of the presentation can be accessed through the following link http://wsw.com/webcast/ladenburg4/yten/ or through the “Investors” section of the Company's website at www.yield10bio.com. The webcast replay will remain available for 90 days following the live presentation.
Yield10 Bioscience, Inc. is focused on developing new technologies to achieve step-change improvements in crop yield to enhance global food security. Yield10 has an extensive track record of innovation based around optimizing the flow of carbon in living systems. Yield10 is leveraging its technology platforms and unique knowledge base to design precise alterations to gene activity and the flow of carbon in plants to produce higher yields with lower inputs of land, water or fertilizer. Yield10 is advancing several yield traits it has developed in crops such as Camelina, canola, soybean and rice. Yield10 is headquartered in Woburn, MA and has an Oilseeds Center of Excellence in Saskatoon, Canada.
For more information about the company, please visit www.yield10bio.com.
Lynne H. Brum, (617) 682-4693, LBrum@yield10bio.com
Amato and Partners, LLC
Fischtank Marketing and PR
Source: Yield10 Bioscience, Inc.